{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T13:03:21Z","timestamp":1775653401154,"version":"3.50.1"},"reference-count":23,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Tuberculosis remains one of the preventable causes of mortality among liver transplant recipients. The prevalence of tuberculosis in solid organ transplant recipients is higher than in the general population. The aim of this study was to evaluate the incidence of latent tuberculosis infection (LTBI) and active tuberculosis after liver transplantation. Methods: This is a retrospective, single-center, case\u2013control study. Adult liver transplant candidates who were evaluated between 1 January 2016 and 31 December 2022 were retrospectively assessed. Patients with pre-transplant tuberculin skin test (TST) and\/or interferon-gamma release assay (IGRA) results who underwent transplantation were included in this study. Results: A total of 111 liver transplant recipients with available IGRA and\/or TST results were included; 70 were men (63.1%) and 41 were women (36.9%), with a mean age of 53.5 \u00b1 11.3 years. Demographic, clinical, and laboratory characteristics were evaluated. The most common indication for liver transplantation was viral hepatitis (33.3%), followed by cryptogenic cirrhosis (19.8%) and hepatocellular carcinoma (10.8%). All patients had a Bacillus Calmette\u2013Gu\u00e9rin (BCG) vaccination scar. Ten patients received grafts from deceased donors, while 101 underwent living-donor liver transplantation. No patient received LTBI treatment before transplantation, whereas LTBI treatment was initiated in four patients after transplantation. None of the patients had a diagnosis of active tuberculosis prior to transplantation. Thoracic computed tomography revealed findings compatible with tuberculosis sequelae in 11 patients (9.9%). During a median follow-up period of 49 [27\u201364] months after transplantation, no cases of active tuberculosis were observed among patients with positive TST and\/or IGRA results. Patients were divided into two groups according to their TST and IGRA results. Group 1 consisted of patients with IGRA positivity and\/or a TST \u2265 5 mm, while Group 2 included patients with a TST &lt; 5 mm and negative IGRA results. The only statistically significant difference between the groups was the administration of LTBI treatment (p = 0.027); four patients in Group 1 received LTBI therapy. None of these patients were able to continue prophylaxis due to treatment-related adverse effects. Conclusions: Prophylaxis with hepatotoxic agents poses a substantial risk in liver transplant candidates. Since the hepatotoxicity may cause early cessation of LTBI treatment, the risk\u2013benefit ratio of post-transplant LTBI therapy should be carefully assessed. In situations where LTBI treatment is deferred, close clinical monitoring is strongly recommended.<\/jats:p>","DOI":"10.3390\/jcm15072803","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T14:00:31Z","timestamp":1775570431000},"page":"2803","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of Latent Tuberculosis Infection Risk in Liver Transplant Recipients"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4382-7513","authenticated-orcid":false,"given":"Mira\u00e7","family":"\u00d6z Kahya","sequence":"first","affiliation":[{"name":"Department of Chest Diseases, Faculty of Medicine, Ankara University, 06620 Ankara, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1645-7761","authenticated-orcid":false,"given":"Serhat","family":"Erol","sequence":"additional","affiliation":[{"name":"Department of Chest Diseases, Faculty of Medicine, Ankara University, 06620 Ankara, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilara","family":"K\u0131\u015f G\u00f6k\u00e7ecik","sequence":"additional","affiliation":[{"name":"Department of Chest Diseases, Faculty of Medicine, Ankara University, 06620 Ankara, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9890-9540","authenticated-orcid":false,"given":"Elvan Onur","family":"K\u0131r\u0131mker","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Faculty of Medicine, Ankara University, 06620 Ankara, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7635-8848","authenticated-orcid":false,"given":"G\u00fcle","family":"\u00c7\u0131nar","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ankara University, 06620 Ankara, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ak\u0131n F\u0131rat","family":"Kocaay","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Faculty of Medicine, Ankara University, 06620 Ankara, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deniz","family":"Balc\u0131","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Faculty of Medicine, Bah\u00e7e\u015fehir University, 34353 Istanbul, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4599-1461","authenticated-orcid":false,"given":"\u00d6zlem","family":"\u00d6zdemir Kumbasar","sequence":"additional","affiliation":[{"name":"Department of Chest Diseases, Faculty of Medicine, Ankara University, 06620 Ankara, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/1469-0691.12641","article-title":"Mycobacterial infections in solid organ transplant recipients","volume":"20","author":"Meije","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/ajt.12100","article-title":"Mycobacterium tuberculosis infections in solid organ transplantation","volume":"13","author":"Subramanian","year":"2013","journal-title":"Am. J. Transplant."},{"key":"ref_3","first-page":"199","article-title":"Evaluation of latent tuberculosis infection in liver transplant recipients","volume":"13","author":"Ahmadinejad","year":"2021","journal-title":"Iran. J. Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ijid.2021.10.043","article-title":"Risk Groups of Developing Active Tuberculosis in Liver Transplant Recipients in a Tuberculosis Endemic Area: Risk Stratification by Chest Image and Interferon Gamma Release Assay","volume":"113","author":"Kim","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1034\/j.1399-0012.2002.01098.x","article-title":"Mycobacterium tuberculosis infection and laboratory diagnosis in solid-organ transplant recipients","volume":"16","author":"Cavusoglu","year":"2002","journal-title":"Clin. Transplant."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.3906\/sag-1803-144","article-title":"Determinants and characteristics of tuberculosis in liver transplant recipients","volume":"48","author":"Abdulleyeva","year":"2018","journal-title":"Turk. J. Med. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1016\/j.transproceed.2013.09.024","article-title":"Evaluation of pulmonary infections in solid organ transplant patients: 12 years of experience","volume":"45","author":"Ozen","year":"2013","journal-title":"Transplant. Proc."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e12920","DOI":"10.1111\/tid.12920","article-title":"Tuberculin skin test, Interferon gamma release assays or just chest X-ray to study latent tuberculosis before solid organ transplantation?","volume":"20","year":"2018","journal-title":"Transpl. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1586\/14737159.8.3.247","article-title":"QuantiFERON-TB Gold assay for the diagnosis of latent tuberculosis infection","volume":"8","author":"Manuel","year":"2008","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1111\/j.1600-6143.2007.02011.x","article-title":"Comparison of quantiferon-TB gold with tuberculin skin test for detecting latent tuberculosis infection prior to liver transplantation","volume":"7","author":"Manuel","year":"2007","journal-title":"Am. J. Transplant."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejim.2007.03.020","article-title":"Limitations of the QuantiFERON-TB Gold test in detecting Mycobacterium tuberculosis infection in immunocompromised patients","volume":"19","author":"Hornum","year":"2008","journal-title":"Eur. J. Intern. Med."},{"key":"ref_12","unstructured":"Ministry of Health (Turkey) (2019). Tuberculosis Diagnosis and Treatment Guidelines."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e13548","DOI":"10.1111\/ctr.13548","article-title":"Screening of donor and candidate prior to solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Malinis","year":"2019","journal-title":"Clin. Transplant."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/j.1600-6143.2011.03626.x","article-title":"The current state of tuberculosis in solid organ transplantation: Three principles for optimal management","volume":"11","author":"Doblas","year":"2011","journal-title":"Am. J. Transplant."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s15010-023-02161-1","article-title":"Safety and outcome of treatment of latent tuberculosis infection in liver transplant recipients","volume":"52","author":"Lee","year":"2024","journal-title":"Infection"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/lt.22319","article-title":"Chest computed tomography is more likely to show latent tuberculosis foci than simple chest radiography in liver transplant candidates","volume":"17","author":"Lyu","year":"2011","journal-title":"Liver Transpl."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1086\/599035","article-title":"Tuberculosis after solid-organ transplant: Incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort","volume":"48","author":"Doblas","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12941-023-00661-4","article-title":"Changes in tuberculosis risk after transplantation in the setting of decreased community tuberculosis incidence: A national population-based study, 2008\u20132020","volume":"23","author":"Hyun","year":"2024","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1086\/597590","article-title":"Tuberculosis in solid-organ transplant recipients: Consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology","volume":"48","author":"Aguado","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1111\/j.1600-6143.2011.03625.x","article-title":"A prospective longitudinal study evaluating the usefulness of a T-cell-based assay for latent tuberculosis infection in kidney transplant recipients","volume":"11","author":"Kim","year":"2011","journal-title":"Am. J. Transplant."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/tid.12555","article-title":"Risk of tuberculosis after lung transplantation: The value of pretransplant chest computed tomography and the impact of mTOR inhibitors and azathioprine use","volume":"18","author":"Santos","year":"2016","journal-title":"Transpl. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e12845","DOI":"10.1111\/tid.12845","article-title":"Tuberculosis after liver transplantation in a large center in New York City: QuantiFERON\u00ae-TB Gold-based pre-transplant screening performance and active tuberculosis post-transplant","volume":"20","author":"Hand","year":"2018","journal-title":"Transpl. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4285\/kjt.22.0036","article-title":"Nationwide survey of infection prevention protocols in solid organ transplantation in South Korea","volume":"36","author":"Huh","year":"2022","journal-title":"Korean J. Transplant."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/7\/2803\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T11:59:12Z","timestamp":1775649552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/7\/2803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":23,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["jcm15072803"],"URL":"https:\/\/doi.org\/10.3390\/jcm15072803","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]}}}